Ionis Pharmaceuticals (IONS) Net Equity Issued and Repurchased (2013 - 2024)
Ionis Pharmaceuticals (IONS) posted quarterly Net Equity Issued and Repurchased of $489.1 million for Q3 2024, down 21.74% quarter-over-quarter from $625.0 million in Q2 2018.
Powered by 
Analysis
Ionis Pharmaceuticals (IONS) Net Equity Issued and Repurchased (2013 - 2024) Analysis & Trends
Ionis Pharmaceuticals' Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $489.1 million for Q3 2024.
- In Q3 2024, Net Equity Issued and Repurchased changed N/A year-over-year to $489.1 million; the TTM figure through Dec 2025 stood at $489.1 million (changed N/A YoY), while the FY2024 annual figure was $489.1 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased for Q3 2024 stood at $489.1 million, down from $625.0 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $489.1 million in Q3 2024, with the low at $489.1 million in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | Ionis Pharmaceuticals | 9.70 Bn | 7.64 Bn | 265.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 489.10 Mn |
| Jun 30, 2018 | 625.00 Mn |
| Sep 30, 2017 | 97,000.00 |
| Mar 31, 2017 | 71.64 Mn |
| Jun 30, 2013 | 173.30 Mn |